Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9RRF

TRPC5 apo cryoEM map in the presence of pluronic acid (PA), state 2

Summary for 9RRF
Entry DOI10.2210/pdb9rrf/pdb
EMDB information54186
DescriptorShort transient receptor potential channel 5, ZINC ION, (2S)-2-(hexadecanoyloxy)-3-hydroxypropyl (9Z)-octadec-9-enoate, ... (6 entities in total)
Functional Keywordsion channel, apo, membrane protein
Biological sourceHomo sapiens (human)
Total number of polymer chains4
Total formula weight363724.08
Authors
Porav, A.S.,Bon, R.S.,Muench, S. (deposition date: 2025-06-27, release date: 2026-05-13)
Primary citationPorav, S.A.,Ptakova, A.,Bauer, C.C.,Hammond, K.L.R.,Beech, D.J.,Vlachova, V.,Muench, S.P.,Bon, R.S.
(-)-Englerin A binding to human TRPC5 exposes an aromatic interaction network in channel activation.
Nat Commun, 2026
Cited by
PubMed Abstract: TRPC4/5 cation channels are polymodal cellular sensors and emerging drug targets in various human pathologies. The plant natural product (-)-englerin A (EA) is a potent, selective TRPC4/5 agonist that has transformed TRPC4/5 research. However, the structural basis of EA-mediated TRPC4/5 activation has remained elusive, limiting our ability to understand and exploit EA's pharmacology. Here, we present nine high-resolution cryo-EM structures of human TRPC5, representing different states and ligand occupancies, which show that EA occupies a conserved lipid binding site between channel subunits. Conformational changes of residues surrounding this binding site - most notably in the aromatic interaction network around Phe520 - result in rearrangement of the pore helices into a pre-open state. Our structural models are consistent with the effects of mutagenesis on EA's potency, efficacy and activation kinetics, and allow us to rationalise competitive inhibition by other TRPC4/5 modulators as well as EA's selectivity profile within the TRPC family. Our structural insights into the mode-of-action of a widely used TRPC4/5 agonist will underpin fundamental TRPC4/5 research and ongoing drug discovery programmes.
PubMed: 42056091
DOI: 10.1038/s41467-026-71840-y
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.3 Å)
Structure validation

253389

PDB entries from 2026-05-13

PDB statisticsPDBj update infoContact PDBjnumon